Condition
Burn Surgery
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
Early P 1 (1)
Trial Status
Unknown3
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05241912Early Phase 1UnknownPrimary
Supernormal Oxygen Delivery for Patients With Severe Burns
NCT03884036Not ApplicableUnknownPrimary
Effect of Vitamin D in Burn Patients
NCT03590873Not ApplicableUnknownPrimary
The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients
NCT00974597Not ApplicableTerminatedPrimary
Comparison of AWBAT™-D and MEPILEX® AG for Treatment of Donor Sites in Burn Surgery
Showing all 4 trials